Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation - Report - MDSpire
Advertisement
Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation
Clinical Report: Predictive Value of SII and Blood Pressure in AF Recurrence
Overview
This study evaluates the systemic immune-inflammation index (SII) as a predictor of atrial fibrillation (AF) recurrence post-ablation in hypertensive patients. It highlights the significant interaction between SII levels and blood pressure control, identifying a high-risk subgroup with markedly increased recurrence risk.
Background
Atrial fibrillation (AF) is a prevalent arrhythmia that poses significant clinical challenges, particularly post-ablation. Hypertension is a major risk factor for AF, with many patients experiencing recurrence after radiofrequency catheter ablation (RFCA). Understanding the role of systemic inflammation, as indicated by the systemic immune-inflammation index (SII), in conjunction with blood pressure management is crucial for optimizing patient outcomes.
Data Highlights
Measure
Value
AF Recurrence Rate
17.3%
Hazard Ratio for SII (per 100-unit increase)
1.138
Hazard Ratio for high SII and poorly controlled BP
4.061
C-statistic for SII model
0.755
Key Findings
Elevated SII is independently associated with increased AF recurrence risk post-RFCA.
Patients with high SII and poorly controlled blood pressure have over a fourfold increased risk of recurrence.
SII outperforms traditional markers like AF duration and left atrial volume in predicting recurrence.
The study emphasizes the importance of blood pressure control in managing AF recurrence risk.
Combining SII and blood pressure control may enhance individualized risk stratification for patients undergoing RFCA.
Clinical Implications
Clinicians should consider pre-ablation SII levels and blood pressure control status when assessing AF recurrence risk in hypertensive patients. This dual assessment may facilitate more tailored management strategies to improve post-ablation outcomes.
Conclusion
The findings underscore the importance of integrating systemic inflammation markers and blood pressure management in predicting AF recurrence, potentially guiding more effective interventions in high-risk patients.
Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
